Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
35.1%
% of GDOC's 39 holdings also in HRTS
32.5%
% of HRTS's 40 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GDOC |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.7% | 10.1% | 9.7% |
|
UNITEDHEALTH GROUP INC | 5.2% | 6.0% | 5.2% |
 |
ASTRAZENECA PLC | 4.2% | 4.1% | 4.1% |
|
ABBOTT LABORATORIES | 5.2% | 3.8% | 3.8% |
 |
NOVO NORDISK A/S-B | 3.8% | 3.9% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to HRTS
|
INTUITIVE SURGICAL INC | 5.8% |
|
BOSTON SCIENTIFIC CORP | 5.3% |
|
ABBVIE INC | 4.0% |
|
COOPER COS INC/THE | 3.8% |
|
BIOMARIN PHARMACEUTICAL INC | 3.3% |
 |
CSL LIMITED | 3.1% |
 |
LONZA GROUP AG-REG | 2.9% |
|
INSULET CORP | 2.7% |
|
VEEVA SYSTEMS INC-CLASS A | 2.5% |
 |
HOYA CORP | 2.5% |
GDOC Underweight Relative to HRTS
|
BRIDGEBIO PHARMA, INC. | -4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.9% |
|
VERTEX PHARMACEUTICALS INC | -3.4% |
|
GILEAD SCIENCES INC | -3.1% |
|
THERMO FISHER SCIENTIFIC INC | -3.1% |
 |
MEDTRONIC PLC | -3.0% |
|
NOVARTIS AG | -2.9% |
|
CRINETICS PHARMACEUTICALS INC | -2.6% |
|
BRISTOL-MYERS SQUIBB CO | -2.6% |
|
CYTOKINETICS INC | -2.3% |